Geriatric gynaecology deals with gynaecological pathology encountered in postmenopausal women at and above 60 years of age with an intention of early diagnosis and management . A major challenge for the world in the 21st century is the ageing of its population. As the life expectancy of postmenopausal women has risen dramatically, hence this study was taken up to analyze incidence, diagnosis, treatment of gynaecological disorders in females aged 60 years and above. METHODS: It is an retrospective observational study of female patients aged 60 years and above, admitted in the department of Obstetrics and Gynaecology, IPGMER and SSKM Hospital, Kolkata over a period of one year. Data was collected from admission and OT register. Age distribution, spectrum of gynaecological disorder, type of surgeries performed, were noted and analyzed. RESULTS: In our study ninety patients were aged 60 years or more amongst total admission of 811 comprising age related incidence of 11.09%. The mean average age of admission was 64.19 years. Uterovaginal prolapse(51.1%) was the commonest clinical problem followed by malignancy (26.7%). Among the gynaecological malignancies (24 patients) ovarian carcinoma was the most common (50%) followed by endometrial carcinoma(33.3%).Total 36 patients of uterovaginal prolapse were managed surgically. All patients of malignancy were treated surgically. Among Nine cases of stress urinary incontinence, seven managed by TVT/TOT. CONCLUSION: Uterovaginal prolapse and malignancy were the major gynaecological problems in older women. In future geriatric gynaecology will play an important role in India, as the size of elderly population is increasing over time.

No abstract

BACKGROUND The leading causes of pregnancy-related deaths are haemorrhage, embolism and hypertensive disorders of pregnancy. Postpartum haemorrhage is a major preventable cause of maternal morbidity and mortality in developing countries. 1 Uterine atony is the main cause of PPH. Therefore, to reduce PPH, we have to address the role of uterotonics. In this context, addition of misoprostol along with WHO recommended 10 units oxytocin in active management of third stage of labour may play an important role. This study was conducted with the aim of comparing the efficacy of Misoprostol plus oxytocin versus oxytocin only for the prevention of post-partum haemorrhage. METHODS This randomized controlled trial was performed at R. G. Kar Medical College and Hospital to compare the efficacy of misoprostol along with oxytocin for the prevention of post-partum haemorrhage (PPH) with oxytocin only in the third stage of labour to prevent of postpartum haemorrhage. 600 women without risk of PPH were randomly allocated to receive either 600 mcg orally, misoprostol along with 10 units of oxytocin intramuscularly (Group I) or 10 units of oxytocin intramuscularly (Group II) within 1 minute of delivery, 300 in each group. The efficacy and the safety of these two drugs were analysed on the basis of percentages fall in haemoglobin (Hb) from pre delivery to 48 completed hours after delivery and also need for blood transfusion. RESULTS 600 mcg orally misoprostol along with 10 unit of oxytocin intramuscularly is better than 10 units of oxytocin intramuscularly to control PPH with minimal side effects. CONCLUSIONS 600 mcg oral misoprostol along with 10 units of oxytocin intramuscularly may be recommended in place of 10 units of oxytocin intramuscularly to control PPH.

BACKGROUND Thyroid stimulating hormone (TSH, Thyrotropin) induces adipogenesis and adipokine production directly and may contribute to the evolution of obesity, independent of any involvement of the thyroid gland. This study has been conducted to evaluate the association of minor disturbances of thyroid function with changes in obesity indicators like Body Mass Index (BMI) & Waist-Hip Ratio (WHR). We wanted to assess the correlation between the serum TSH level and the various obesity indicators.

No abstract